Scottish public supports expansion of pharmacy roles
Pharmacy teams across Scotland are working towards taking on a wider range of roles by 2030, and a new survey from Ipsos-MORI shows that the Scottish public supports this.
Most people have received c (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 8, 2022 Category: Drugs & Pharmacology Source Type: news
Free access for Ukraine to Medicines Complete and the Pharmaceutical Journal
Commenting on invasion of Ukraine by Russia, RPS President Professor Claire Anderson said“We are deeply troubledbythedevastatingcrisis in Ukraine and our thoughts are with all those impacted. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 8, 2022 Category: Drugs & Pharmacology Source Type: news
Update on RPS proposed Executive structure
Commenting on a proposed change to the Executive structure, RPS President Professor Claire Anderson said:“I deeply regret seeing so much speculation in the public domain about a proposed chang (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 4, 2022 Category: Drugs & Pharmacology Source Type: news
National Patient Safety Alert
UK Health Security Agency has issued a national patient safety alert: potential contamination of Alimentum and Elecare infant formula food products. On 20 February 2022, the Food Standards Agency (FSA (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 4, 2022 Category: Drugs & Pharmacology Source Type: news
Community Pharmacy Ventilation Funding in Scotland
Scottish Government has announced that funding is being made available to help community pharmacy contractors purchase air extraction equipment for their premises.
This funding will support both staf (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 4, 2022 Category: Drugs & Pharmacology Source Type: news
Class 3 Medicines Recall: Kyowa Kirin Services Ltd. Isotard 60mg XL Tablets
Kyowa Kirin Services Ltd. are recalling a batch of Isotard 60mg XL Tablets as a precautionary measure due to microfibres/crystals of the Active Pharmaceutical Ingredient (API) being present on the sur (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 2, 2022 Category: Drugs & Pharmacology Source Type: news
Help shape the future of pharmacy and integrated care
We’re hosting two sessions for members to help shape our response to an NHS review of primary care in England.
The‘Fuller Stocktake’ review is looking at how primary care can help (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 1, 2022 Category: Drugs & Pharmacology Source Type: news
UPDATE: MHRA Class 4 Medicines Defect Information: Atnahs Pharma UK Limited, Naprosyn Tablets (all strengths), Naprosyn EC 250mg Gastro-Resistant Tablets, Naprosyn EC 500mg Gastro-Resistant Tablets
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued an update, following the medicines defect notification shared on 23 February 2022, this has been updated to reflect an update (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 1, 2022 Category: Drugs & Pharmacology Source Type: news
Take a look back at our LGBTQIA+ History Month content
Throughout February we celebrated LGBTQIA History Month.
Take a look:
Our brand new guide to LGBTQIA+ microaggressions highlights discrimination based on someone’s sexual orientation and their (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 25, 2022 Category: Drugs & Pharmacology Source Type: news
RPS England responds to NAO report
This report highlights t (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 25, 2022 Category: Drugs & Pharmacology Source Type: news
Remdesivir for patients hospitalised due to COVID-19 (adults and adolescents 12 years and older)
A COVID-19 therapeutic alert has been issued: Remdesivir for patients hospitalised due to COVID-19 (adults and adolescents 12 years and older)
The published policy has been updated to reflect the lat (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 24, 2022 Category: Drugs & Pharmacology Source Type: news
Antivirals and neutralising monoclonal antibodies in the treatment of Covid-19 in hospitalised Patients
A COVID-19 therapeutic alert has been issued: neutralising monoclonal antibodies (nMABs) and antivirals for treatment of Covid-19 hospitalised patients.
The policy has been updated to reflect the wit (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 24, 2022 Category: Drugs & Pharmacology Source Type: news
Living with COVID-19 (England) & COVID-19 Strategic Framework update (Scotland)
Living with COVID-19 - England
The government have outlined the plan for Living with COVID-19.
NHS England has written to the NHS system with an initial update in the light of this plan and to outlin (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 24, 2022 Category: Drugs & Pharmacology Source Type: news
Class 4 Medicines Defect Information: Atnahs Pharma UK Limited, Naprosyn Tablets (all strengths), Naprosyn EC 500mg Gastro-Resistant Tablets
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 medicines defect information for Atnahs Pharma UK Limited, Naprosyn Tablets (all strengths) and Naprosyn EC 500mg Ga (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 23, 2022 Category: Drugs & Pharmacology Source Type: news
JCVI statement on vaccination of children aged 5 to 11 years old
The Joint Committee on Vaccination and Immunisation (JCVI) have reviewed evidence on the potential impact of extending COVID-19 vaccination to other children aged 5 to 11. JCVI advises a non-urgent of (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 23, 2022 Category: Drugs & Pharmacology Source Type: news
